Main Article Content
Abstract
Background: A wound is a disorder of the continuity of the epithelial layer of the skin or mucosa and can result from physical or thermal damage. Proliferation and remodeling processes are important phases in incision wound healing. Celery is believed to have the potential to regulate the inflammatory phase and accelerate the process of proliferation and remodeling of wound tissue. This study aims to evaluate the potency of celery extract (Apium graveolens (Linn)) on incision wound healing in vivo.
Methods: This study was an in vivo experimental study. A total of 24 rats were used in this study and divided into 4 treatment groups (2 control and 2 treatment groups). Analysis of epithelial thickness ratio and epithelial length was performed using SPSS using univariate and bivariate.
Results: The control group had the lowest epithelial thickness ratio, followed by 50% extract, 75% extract, and finally, the gentamicin group. The length of newly formed epithelium in wounds treated with Apium graveolens (Linn) extract group 70% (mean 1.461 mm) was similar to that treated with gentamicin 0.1% (mean 1.457 mm) and much better than those treated without extract (0.869 mm).
Conclusion: Celery extract (Apium graveolens (Linn)) has the potential to accelerate the process of reepithelialization of incision wounds in vivo studies.
Keywords
Article Details
As our aim is to disseminate original research article, hence the publishing right is a necessary one. The publishing right is needed in order to reach the agreement between the author and publisher. As the journal is fully open access, the authors will sign an exclusive license agreement.
The authors have the right to:
- Share their article in the same ways permitted to third parties under the relevant user license.
- Retain copyright, patent, trademark and other intellectual property rights including research data.
- Proper attribution and credit for the published work.
For the open access article, the publisher is granted to the following right.
- The non-exclusive right to publish the article and grant right to others.
- For the published article, the publisher applied for the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.